| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |